• Home
  • Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.

Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.

Author List
Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, Tetsu O
Publication
Human molecular genetics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1457092
Publication Year
2007
PubMed ID
17981815
Publication Title
Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, Tetsu O. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Hum Mol Genet. 2008 Feb 01; 17(3):419-30.